REDNESS SOLUTIONS MAKEUP

Product NDC: 49527-005
11-digit product format: 495270005
Labeler code: 49527
Product ID: 49527-005_651ed07d-d801-458b-bb84-3ca903a55303
Type: HUMAN OTC DRUG
Nonproprietary name: OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE
Dosage form: LOTION
Route: TOPICAL
Labeler: CLINIQUE LABORATORIES INC
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2010-12-01
Marketing end: 0000-00-00
Substance: OCTINOXATE; ZINC OXIDE; TITANIUM DIOXIDE
Active strength: 6 mL/100mL; mL/100mL; mL/100mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	49527-005		I	Inactivated by FDA		2026-10-05
excluded package	package	49527-005	49527-005-01	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	49527-005-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	49527-005-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	49527-005-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	49527-005-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	49527-005-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	49527-005-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	49527-005-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	49527-005-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	49527-005-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	49527-005-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49527-005-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49527-005-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	49527-005-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	49527-005-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	49527-005-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	49527-005-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	49527-005-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	49527-005-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	49527-005-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	49527-005-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	49527-005-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	49527-005-01	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49527-005-01	2020-01-31	C162847	48780-1	9d75b9d0-5062-f424-e053-dadaa90a57ce	361d7f45-22f4-440f-b9e6-312618e48298

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
49527-005-01	REDNESS SOLUTIONS MAKEUPSPF 15 WITH PROBIOTIC TECHNOLOGY	1 in 1 CARTON	LOTION	1		1
49527-005-02	REDNESS SOLUTIONS MAKEUPSPF 15 WITH PROBIOTIC TECHNOLOGY	30 mL in 1 BOTTLE	LOTION	30		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
ALPHA-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
ALUMINUM HYDROXIDE	INACTIVE INGREDIENT	5QB0T2IUN0	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
ASTROCARYUM MURUMURU SEED BUTTER	INACTIVE INGREDIENT	12V64UPU6R	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
CAFFEINE	INACTIVE INGREDIENT	3G6A5W338E	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
CITRUS MAXIMA FRUIT RIND	INACTIVE INGREDIENT	5NX3G75CA6	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
DIPROPYLENE GLYCOL	INACTIVE INGREDIENT	E107L85C40	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
FU LING	INACTIVE INGREDIENT	XH37TWY5O4	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
LACTOBACILLUS HELVETICUS	INACTIVE INGREDIENT	Q08Z44662J	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
MAGNOLIA GRANDIFLORA BARK	INACTIVE INGREDIENT	J4XF5T6418	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
METHYL TRIMETHICONE	INACTIVE INGREDIENT	S73ZQI0GXM	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
MICA	INACTIVE INGREDIENT	V8A1AW0880	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
PHENYL TRIMETHICONE	INACTIVE INGREDIENT	DR0K5NOJ4R	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
POLYAMINOPROPYL BIGUANIDE	INACTIVE INGREDIENT	322U039GMF	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
SODIUM MYRISTOYL ISETHIONATE	INACTIVE INGREDIENT	8D42TA2T6V	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
TRIETHYLHEXANOIN	INACTIVE INGREDIENT	7K3W1BIU6K	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
TRIMETHOXYCAPRYLYLSILANE	INACTIVE INGREDIENT	FZ07E4LW2M	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49527-005	REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY (OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE) LOTION [CLINIQUE LABORATORIES INC]	1	Legacy NDC, 2 package rows	20110711_361d7f45-22f4-440f-b9e6-312618e48298.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
SOI2LOH54Z	ZINC OXIDE	1314-13-2	ZINC OXIDE
15FIX9V2JP	TITANIUM DIOXIDE	13463-67-7	TITANIUM DIOXIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
49527-005-01	49527000501	1 in 1 CARTON		Historical
49527-005-02	49527000502	30 mL in 1 BOTTLE	30 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY	CLINIQUE LABORATORIES INC \| ESTEE LAUDER COSMETICS, LTD \| ESTEE LAUDER N.V. \| Len-Ron Manufacturing Division of Aramis Inc. \| Aramis Inc. \| Northtec Bristol \| Northtec Keystone \| Estee Lauder Pennsylvania Distribution Center 2 \| Estee Lauder Cosmetics, Ltd. \| Estee Lauder Cosmetics Distribution Center \| Estee Lauder Kabushiki Kaisha \| Whitman Laboratories Ltd. \| Aveda Corporation	2011-07-07	HUMAN OTC DRUG LABEL	1